This Triac trial was not designed to detect any impact of the treatment on neurodevelopmental outcomes in human MCT8 deficiency although a trend towards neurodevelopmental improvement was noted in a subset of patients in an exploratory analysis. Here, SLC16A2 is linked to hyperinsulinemic hypoglycemia, familial, 4.